ID

41452

Description

Study ID: 107671 Clinical Study ID: 107671 Study Title: EGF107671 – A Phase II Study of Lapatinib plus Topotecan or Lapatinib plus Capecitabine in the Treatment of Recurrent Brain Metastases from ErbB2-Positive Breast Cancer Following Cranial Radiotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00437073 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: N/A Trade Name: capecitabine, topotecan, lapatinib Study Indication: Neoplasms, Breast; Recurrent Brain Metastases

Mots-clés

Versions (1)
  1. 13/10/2020 13/10/2020 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

13 octobre 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Lapatinib + Topotecan or + Capecitabine in Recurrent Brain Metastases from Breast Cancer; NCT00437073

Anglais

Survival Follow-Up

1 Formulaires  
  1. StudyEvent: ODM
    1. Survival Follow-Up
Date of Visit/Assessment
Description

Date of Visit/Assessment

Alias
UMLS CUI-1
C1320303
UMLS CUI-2
C2985720
Date of visit/assessment
Description

Date of visit; Assessment Date

Type de données

date

Alias
UMLS CUI [1]
C1320303
UMLS CUI [2]
C2985720
Survival Follow-Up
Description

Survival Follow-Up

Alias
UMLS CUI-1
C1522577
UMLS CUI-2
C0038952
Is the subject alive?
Description

Alive (finding)

Type de données

text

Alias
UMLS CUI [1]
C2584946
Date of Contact
Description

Alive (finding), Date last contact

Type de données

date

Alias
UMLS CUI [1,1]
C2584946
UMLS CUI [1,2]
C0805839
Has the subject started any new anti-cancer therapy since the last contact?
Description

Cancer treatment, New

Type de données

text

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205314
Yes, Start Date
Description

Cancer treatment, New, Start Date

Type de données

date

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205314
UMLS CUI [1,3]
C0808070
Retour au début de la page

Similar models

Survival Follow-Up

1 Formulaires
  1. StudyEvent: ODM
    1. Survival Follow-Up
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Date of Visit/Assessment
C1320303 (UMLS CUI-1)
C2985720 (UMLS CUI-2)
Date of visit; Assessment Date
Item
Date of visit/assessment
date
C1320303 (UMLS CUI [1])
C2985720 (UMLS CUI [2])
Item Group
Survival Follow-Up
C1522577 (UMLS CUI-1)
C0038952 (UMLS CUI-2)
Item
Is the subject alive?
text
C2584946 (UMLS CUI [1])
Level of consciousness
Code List
Is the subject alive?
CL Item
Yes, complete Date of Contact (1)
CL Item
No, complete Death and Study Conclusion forms (2)
Alive (finding), Date last contact
Item
Date of Contact
date
C2584946 (UMLS CUI [1,1])
C0805839 (UMLS CUI [1,2])
Item
Has the subject started any new anti-cancer therapy since the last contact?
text
C0920425 (UMLS CUI [1,1])
C0205314 (UMLS CUI [1,2])
Cancer treatment, New
Code List
Has the subject started any new anti-cancer therapy since the last contact?
CL Item
Yes, complete Start Date (1)
CL Item
No (2)
Cancer treatment, New, Start Date
Item
Yes, Start Date
date
C0920425 (UMLS CUI [1,1])
C0205314 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial